Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Gibson Christopher. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. In total, 29 disclosures have been published. History available since 5 June 2026. The latest transaction was filed on 21 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gibson Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
100,000 shares@ US$3.7450.018% mcap6.5% of flowClass ASEC144:0001959173-26-005052
25 of 29 declarations
About Gibson Christopher
Gibson Christopher is a former director of Recursion Pharmaceuticals, INC. (XNAS). He has 17 filings in total, and across the sampled recent filings from 2026-06-05 to 2026-07-21, they relate only to sales, for a total of EUR 6824834, with the most common transaction nature being a notice of proposed sale (Form 144).